<p>2.1.1 Preparation of drug-laden Gel/HA composite</p>
<p>Alendronate
(ALN), is a commonly used bisphosphonate drug for osteoporosis management and bone
regeneration. <sup>[33] </sup>However, direct
loading of ALN onto Gel often results in burst drug release due to the fast Gel
degradation <i>in vivo</i>. In
contrast, degradable HA microsphere is an excellent drug delivery vehicle,
which can provide sustained/controlled drug release as well as promoting osteoblasts mineralization/maturation (due to slow release of Ca<sup>2+</sup>
and PO<sub>4</sub><sup>3-</sup>). <sup>[34]</sup> To prepare the ALN-laden HA microspheres/Gel
composite (ALN-HA/Gel), HA microspheres were first synthesized following established procedure.<sup> [35]</sup> 0.5 g ALN was then added into 50 mL aqueous dispersion containing 2.0 g
HA microspheres. After mixing using shaking incubator under 37 ℃ for
48 h, ALN-HA were collected by centrifugation and vacuum dried
at 40 ℃ for 24 h. ALN concentration in the supernatant solution was evaluated
by UV-vis spectroscopy. The drug-laden Gel/ALN-HA can be obtained by
dispersing 3.0g ALN-HA
microspheres in 50 mL deionized water, followed by addition of 8.0 g Gel, and
stirred magnetically at 1000 rpm under 50 ℃ for 1 h.</p>
<p>2.1.2 Preparation of 3D printed
Ti6Al4V scaffolds</p>
<p>3D
printed Ti6Al4V scaffolds (named as Ti) were manufactured by electron beam
melting (EBM) facility in-house. The lattice structure was designed by
computer-assisted design (CAD) software (Magics, Materialise, Belgium) based on
a dodecahedron unit cell with strut diameter of 300 μm and porosity of 80%.
Cubic scaffolds (5mm × 5mm × 5mm) were used for <i>in vitro</i> testing and cylindrical scaffolds (Φ = 6mm, height = 6mm) were used for <i>in vivo</i>
experiments. All samples were thoroughly cleaned by sonication in acetone,
alcohol and deionized water for 30 min, respectively. The Ti scaffolds were subsequently
subjected to hydrothermal treatment.<sup> [36]</sup> Specifically, the
scaffolds were immersed in an aqueous solution (m(H<sub>2</sub>O<sub>2</sub>):m(H<sub>3</sub>PO<sub>4</sub>)
9:1) and placed in a Teflon-lined autoclave under 220 ℃ for 24 h. After the treatment, scaffolds were
washed with distilled water and dried in air at room temperature for 24 h. The
hydrothermally treated samples were named as HR-Ti.</p>
<p>2.1.3 Preparation of Gel/ALN-HA infused HR-Ti scaffold</p>
<p>The Gel/ALN-HA mixture was infused into the HR-Ti,
then the infused scaffolds were held at -80<a> </a>℃ overnight followed by freeze-drying at -40 ℃ for 48 h. After that, the infused scaffolds
were immersed in 100 mL ethanol containing 50mmol/L 1-ethyl-3-(3- (dimethylamino)
propyl) carbodiimide hydrochlorid (EDC∙HCl) and N-hydroxysuccinimide (NHS) at 4
℃ for 10
h to crosslink the Gel content. Afterwards, the scaffolds were washed three
times by ethanol and freeze-dried again. The final scaffolds were named as
Gel/ALN-HA/HR-Ti. For comparison, ALN/HR-Ti (without Gel and HA), Gel/ALN/HR-Ti
(without HA) and Gel/HA/HR-Ti (without ALN) were also prepared.</p>